Replies to post #4148 on Ayala Pharmaceuticals Inc (ADXS)

[deckheight]

hd, besides the 2 fast track designations you left out the special protocol assessment for our upcoming ph 3 cervical cancer study and our 4 FDA orphan drug designations as well as the 2 additional European Union odd designations...

What next???